Medical Net, Inc.
3645.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥6,071,466 | ¥5,252,061 | ¥4,500,846 | ¥3,745,765 |
| % Growth | 15.6% | 16.7% | 20.2% | – |
| Cost of Goods Sold | ¥4,111,831 | ¥3,411,058 | ¥2,719,711 | ¥2,285,724 |
| Gross Profit | ¥1,959,635 | ¥1,841,003 | ¥1,781,135 | ¥1,460,041 |
| % Margin | 32.3% | 35.1% | 39.6% | 39% |
| R&D Expenses | ¥0 | ¥7,000 | ¥0 | ¥8,000 |
| G&A Expenses | ¥0 | ¥173,000 | ¥157,000 | ¥149,000 |
| SG&A Expenses | ¥1,865,364 | ¥1,542,000 | ¥1,401,000 | ¥1,010,000 |
| Sales & Mktg Exp. | ¥0 | ¥119,000 | ¥119,000 | ¥108,000 |
| Other Operating Expenses | ¥0 | -¥6,278 | ¥483 | -¥3,081 |
| Operating Expenses | ¥1,865,364 | ¥1,542,722 | ¥1,401,483 | ¥1,014,919 |
| Operating Income | ¥94,271 | ¥298,281 | ¥379,650 | ¥445,120 |
| % Margin | 1.6% | 5.7% | 8.4% | 11.9% |
| Other Income/Exp. Net | -¥69,083 | -¥145,231 | -¥128,907 | ¥88,656 |
| Pre-Tax Income | ¥25,188 | ¥153,050 | ¥250,743 | ¥533,776 |
| Tax Expense | ¥62,813 | ¥126,667 | ¥141,896 | ¥137,861 |
| Net Income | -¥68,147 | ¥5,959 | ¥116,181 | ¥380,100 |
| % Margin | -1.1% | 0.1% | 2.6% | 10.1% |
| EPS | -7.64 | 0.66 | 12.97 | 43.44 |
| % Growth | -1,257.6% | -94.9% | -70.1% | – |
| EPS Diluted | -7.64 | 0.66 | 12.97 | 43.44 |
| Weighted Avg Shares Out | 8,924 | 9,045 | 8,961 | 8,751 |
| Weighted Avg Shares Out Dil | 8,924 | 9,045 | 8,961 | 8,751 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥3,701 | ¥1,143 | ¥841 | ¥690 |
| Interest Expense | ¥11,559 | ¥6,422 | ¥3,026 | ¥1,974 |
| Depreciation & Amortization | ¥76,596 | ¥53,815 | ¥62,072 | ¥35,063 |
| EBITDA | ¥113,346 | ¥213,291 | ¥315,839 | ¥570,812 |
| % Margin | 1.9% | 4.1% | 7% | 15.2% |